CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Gossamer Bio (GOSS) Stock Sees Fair Value Cut As Analysts Split On Seralutinib

SeralutinibNegative
AI Analysis

Summary

Gossamer Bio (GOSS) stock experiences analyst fair value cuts amid divided sentiment regarding the seralutinib program.

Importance:3/10
Sentiment:
-0.30
analyst_ratingvaluation_cutanalyst_splitdrug_candidate
Related Companies

Read the original article

Published by yahoo_finance on August 17, 2026 3:17 AM

Read Original